ES2066753T3 - Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas. - Google Patents

Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas.

Info

Publication number
ES2066753T3
ES2066753T3 ES87101849T ES87101849T ES2066753T3 ES 2066753 T3 ES2066753 T3 ES 2066753T3 ES 87101849 T ES87101849 T ES 87101849T ES 87101849 T ES87101849 T ES 87101849T ES 2066753 T3 ES2066753 T3 ES 2066753T3
Authority
ES
Spain
Prior art keywords
preparation
aids
therapy
prophylaxis
people
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87101849T
Other languages
English (en)
Spanish (es)
Inventor
Hans Dipl Chem Dr Schleussner
Herbert Dr Dichtelmuller
Wolfgang Dipl Chem Dr Stephan
Reinhard Dipl Chem Dr Lissner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Pharma GmbH
Original Assignee
Biotest Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6294255&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2066753(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotest Pharma GmbH filed Critical Biotest Pharma GmbH
Application granted granted Critical
Publication of ES2066753T3 publication Critical patent/ES2066753T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C07K16/114—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES87101849T 1986-02-17 1987-02-10 Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas. Expired - Lifetime ES2066753T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863604947 DE3604947A1 (de) 1986-02-17 1986-02-17 Verfahren zur herstellung eines immunglobulinhaltigen praeparates und dessen verwendung zur prophylaxe und therapie von aids

Publications (1)

Publication Number Publication Date
ES2066753T3 true ES2066753T3 (es) 1995-03-16

Family

ID=6294255

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87101849T Expired - Lifetime ES2066753T3 (es) 1986-02-17 1987-02-10 Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas.

Country Status (6)

Country Link
EP (1) EP0234405B1 (enExample)
JP (1) JPS62192326A (enExample)
AT (1) ATE115863T1 (enExample)
DE (2) DE3604947A1 (enExample)
ES (1) ES2066753T3 (enExample)
GR (1) GR3014952T3 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
DE3832578A1 (de) * 1987-09-29 1989-06-01 Spagyrik Heinz Inst Ag Arzneimittel zur bekaempfung der hiv-virus-infektion
JP2613409B2 (ja) * 1987-11-20 1997-05-28 株式会社ミドリ十字 抗エイズウイルス抗体陽性静注用免疫グロブリン製剤の製造方法
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
FR2640145B1 (fr) * 1988-12-12 1991-08-23 Res Education Inst Inc Ensemble pour le traitement du sida
FR2640511B1 (fr) * 1988-12-15 1993-04-23 Merieux Inst Medicaments pour le traitement ou la prevention par immunisation passive de l'infection par le virus hiv et procede de preparation
DE4041114C2 (de) * 1990-12-21 1994-02-17 Michael Dr Med Gruenspan Arzneimittel enthaltend eine IgG 2a-Antikörperfraktion aus Körperflüssigkeiten von HIV-infizierten Patienten
TW541179B (en) * 1997-03-19 2003-07-11 Green Cross Corp Process for preparing immunoglobulin preparation
DK1581644T3 (da) 2003-01-09 2007-10-08 Genentech Inc Oprensning af polypeptider

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
JPS5848855A (ja) * 1981-09-17 1983-03-22 Green Cross Corp:The ＨＢｅ抗原の製法及びＨＢｅ抗体の検出試薬
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients

Also Published As

Publication number Publication date
EP0234405A2 (de) 1987-09-02
EP0234405A3 (en) 1989-03-15
DE3604947C2 (enExample) 1992-03-12
GR3014952T3 (en) 1995-05-31
ATE115863T1 (de) 1995-01-15
DE3604947A1 (de) 1987-08-20
DE3750886D1 (de) 1995-02-02
JPS62192326A (ja) 1987-08-22
EP0234405B1 (de) 1994-12-21

Similar Documents

Publication Publication Date Title
SE8704298D0 (sv) Compounds for use in therapy
ES2133138T3 (es) Nucleosidos terapeuticos.
ES2113347T3 (es) Procedimiento para la desactivacion de virus en sangre y en productos de sangre.
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
ES2152483T3 (es) Aplicacion terapeutica en anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de celulas b.
ES2054641T3 (es) Utilizacion de enzimas catabolicas para la preparacion de un medicamento destinado a combatir la inmunodeficiencia adquirida (sida) y sus etapas previas (sla y crs).
ES2051641B1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
ES2066753T3 (es) Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
PT777669E (pt) Utilizacao de succinato de 4-(2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-ciclopenteno-1-metanol como agente antiviral
ES2121065T3 (es) Composicion para estabilizar el plasma sanguineo durante el pasteurizado y procedimiento de pasteurizado que comprende la utilizacion de esta composicion.
DE60009146D1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten
ATE79254T1 (de) Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen.
DK0410749T3 (da) Anthocyanidiner til behandling af ophthalmiske sygdomme
IT7822027A0 (it) Apparecchio medicale per la cura della trombosi venale profonda.
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
FI881123A0 (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
DE3874606D1 (de) Behandlung von viraler infektion.
GB8728453D0 (en) Agents for removing human immunodeficiency virus & related compounds
ES2059615T3 (es) Empleo del derivado de tiazol tiprotimoda para la preparacion de un agente para la terapia de infecciones por virus.
ATE67931T1 (de) Butylhydroxyanisole zur behandlung von retrovirus-krankheiten.
PT98190A (pt) Processo para a preparacao de composicoes farmaceuticas para estabilizar o plasma sanguineo durante a pasteurizacao
ES2179067T3 (es) Complejo inmunomodulador anti-sida.
ES2059826T3 (es) Utilizacion de quimotripsina para inactivar el activador de precalicreina en productos sanguineos derivados de plasma humano o animal.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 234405

Country of ref document: ES